AgingResearch.NewsJoin free

DALIM TISSEN

CompanySouth Korea

DALIM TISSEN develops one asset, in human trials (CartiPRO in cartilage defects of the knee). Mostly protein or enzyme; based in South Korea.

1
Asset
Furthest stage
Human trials
1
Trial
0
Signals

Pipeline

1

  • CartiPRO

    Intra-articular atelocollagen injection providing structural matrix supplementation for cartilage repair and pain relief.

    Human trials, Protein or enzyme, cartilage defects of the knee, degenerative joint disease of knee

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals1
  • Similar companies6

Intelligence